Contact
searchSearch
HMP Global

Volume 17 - Issue 2 - February, 2005

Teaching Collection
*Saving Time, Saving Money: A Time and Motion Study with Contrast Management Systems
08/01/2008
Craig Lehmann, PhD; Mary Hotaling, MS
In 1929, in an attempt to find a safe way to inject drugs for cardiac resuscitation, a young surgical resident named Werner Forssmann inserted a catheter in his antecubital vein, positioning the catheter into the right atrium of the heart. He...
In 1929, in an attempt to find a safe way to inject drugs for cardiac resuscitation, a young surgical resident named Werner Forssmann inserted a catheter in his antecubital vein, positioning the catheter into the right atrium of the heart. He...
In 1929, in an attempt to find a...
08/01/2008
Journal of Invasive Cardiology
Commentary
Letters to the Editor
08/01/2008
In response to: W.C. Kang, et al, Vol. 16, No. 12, pp. 725–726 Successful Management of a Resistant, Focal Calcified Lesion Following Direct Coronary Stenting with a Cutting Balloon I would like to commend Kang, et al for their innovative...
In response to: W.C. Kang, et al, Vol. 16, No. 12, pp. 725–726 Successful Management of a Resistant, Focal Calcified Lesion Following Direct Coronary Stenting with a Cutting Balloon I would like to commend Kang, et al for their innovative...
In response to: W.C. Kang, et...
08/01/2008
Journal of Invasive Cardiology
Editorial Message
Feb-05
08/01/2008
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports and reports with brief reviews, as well as articles from our special sections Interventional Pediatric Cardiology,...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports and reports with brief reviews, as well as articles from our special sections Interventional Pediatric Cardiology,...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
Case Report
Symbiot‚Ñ¢ Stent Delivery Via 8 Fr Guiding Catheter from the Right Radial Artery in an Acute Coronary Syndrome Due to a Degenerati
08/01/2008
Mark S. Patterson, MBBS, PhD, MD, MRCP; Matthew Banks, MD; Ferdinand Kiemeneij, MD, PhD
Recent studies have demonstrated that in the setting of acute coronary syndrome (ACS), with either intractable symptoms, acute left ventricular failure, acute mitral regurgitation, cardiac enzyme rise or electrocardiogram (ECG) change,...
Recent studies have demonstrated that in the setting of acute coronary syndrome (ACS), with either intractable symptoms, acute left ventricular failure, acute mitral regurgitation, cardiac enzyme rise or electrocardiogram (ECG) change,...
Recent studies have demonstrated...
08/01/2008
Journal of Invasive Cardiology
Case Report
Intra-operative Stenting of a Prosthetic Left Pulmonary Artery Stenosis Under Fluoroscopy
08/01/2008
Gian B. Danzi, MD; Federico Brunelli, MD; Andrea Amaducci, MD
Intraoperative stent placement under direct vision as a means of relieving pulmonary artery stenosis is an attractive alternative to complex surgical reconstruction or a valid option in patients with a limited vascular access.1,2 We describe...
Intraoperative stent placement under direct vision as a means of relieving pulmonary artery stenosis is an attractive alternative to complex surgical reconstruction or a valid option in patients with a limited vascular access.1,2 We describe...
Intraoperative stent placement...
08/01/2008
Journal of Invasive Cardiology
Percutaneous Closure of a Post-traumatic Muscular Ventricular Septal Defect Using the Amplatzer Duct Occluder
08/01/2008
Ziyad M. Hijazi, MD, MPH; Roberto M. Lang, MD; Stephanie Schwalm, MD
Post-traumatic ventricular septal defect (VSD) after penetrating cardiac trauma is infrequent, with an estimated incidence of 1–4.5% of cases.1,3 The decision to close a traumatic VSD is similar to that of a non-traumatic VSD and is based on...
Post-traumatic ventricular septal defect (VSD) after penetrating cardiac trauma is infrequent, with an estimated incidence of 1–4.5% of cases.1,3 The decision to close a traumatic VSD is similar to that of a non-traumatic VSD and is based on...
Post-traumatic ventricular...
08/01/2008
Journal of Invasive Cardiology
Case Report
Reversible Severe Ischemic Mitral Regurgitation and Cardiogenic Shock as a Complication of Percutaneous Coronary Intervention
08/01/2008
Mohammad Reza Movahed, MD, PhD, FACP, FACC, FSCAI; Harry Balian, MD; Pardise Moraghebi, MD
Coronary artery occlusion during percutaneous coronary intervention (PCI) causes regional myocardial ischemia. There are few reports or experimental studies about new onset of transient acute mitral regurgitation (MR) during PCI. However,...
Coronary artery occlusion during percutaneous coronary intervention (PCI) causes regional myocardial ischemia. There are few reports or experimental studies about new onset of transient acute mitral regurgitation (MR) during PCI. However,...
Coronary artery occlusion during...
08/01/2008
Journal of Invasive Cardiology
Case Report
A Novel Technique for Coronary Bifurcation Lesions: Cutting Balloons, Drug-Eluting Stents and the Kissing Technique
08/01/2008
Scott A. Harding, MD, RT(R)(CV); Christopher B. Wong, MD, FACC
Bifurcation coronary lesions remain challenging for interventional cardiologists. Before coronary stents were widely used, the rate of success of percutaneous revascularization was low and the procedure was fraught with complications and...
Bifurcation coronary lesions remain challenging for interventional cardiologists. Before coronary stents were widely used, the rate of success of percutaneous revascularization was low and the procedure was fraught with complications and...
Bifurcation coronary lesions...
08/01/2008
Journal of Invasive Cardiology
Case Report
Use of Everolimus-eluting Stent with a Bioresorbable Polymer Coating for Treatment of Recurrent In-stent Restenosis
08/01/2008
Kaname Takizawa, MD; Taiichiro Meguro, MD, PhD; Hidehiko Honda, MD; Shogen Isoyama, MD
In-stent restenosis (ISR) often limits the long-term success of percutaneous coronary intervention. A number of clinical trials have shown that drug-eluting stents are both safe and effective in preventing ISR in de novo lesions.1,2,3 The use...
In-stent restenosis (ISR) often limits the long-term success of percutaneous coronary intervention. A number of clinical trials have shown that drug-eluting stents are both safe and effective in preventing ISR in de novo lesions.1,2,3 The use...
In-stent restenosis (ISR) often...
08/01/2008
Journal of Invasive Cardiology
Case Report
Rotational Ablation of an Unexpandable Sirolimus-Eluting Stent
08/01/2008
George Louridas, MD; Dimitrios Tsikaderis, MD
The use of rotational atherectomy to ablate part of a metallic stent has been very limited, mainly because there are a small number of candidates for this type of procedure,1–7 but probably also because of the concern regarding the size and...
The use of rotational atherectomy to ablate part of a metallic stent has been very limited, mainly because there are a small number of candidates for this type of procedure,1–7 but probably also because of the concern regarding the size and...
The use of rotational...
08/01/2008
Journal of Invasive Cardiology
Case Report
Unexpected Adverse Effects of Coronary Brachytherapy Remote from Intended Target
08/01/2008
Samuel M. Butman, MD; Gurpreet Baweja, MD; Raghunandan Kamineni, MD
Vascular brachytherapy using beta and gamma radiation was the standard for percutaneous reintervention in patients with in-stent restenosis.1–4 While its beneficial effect has been excellent, the development of new lesions at the proximal and...
Vascular brachytherapy using beta and gamma radiation was the standard for percutaneous reintervention in patients with in-stent restenosis.1–4 While its beneficial effect has been excellent, the development of new lesions at the proximal and...
Vascular brachytherapy using...
08/01/2008
Journal of Invasive Cardiology
Correlations Between Cardiac Troponin I, Cardiac Troponin T, and Creatine Phosphokinase MB Elevation Following Successful Percut
08/01/2008
Arda Sanli, MD; Nese Cam, MD; Huseyin Uyarel, MD; Ertan Okmen, MD; Hulya Kasikcioglu, MD
Measurement of cardiac troponins has gained a leading position in the field of biochemical diagnosis of myocardial necrosis, as compared with conventional creatine kinase-MB (CK-MB) measurement. Data reported during the past decade have...
Measurement of cardiac troponins has gained a leading position in the field of biochemical diagnosis of myocardial necrosis, as compared with conventional creatine kinase-MB (CK-MB) measurement. Data reported during the past decade have...
Measurement of cardiac troponins...
08/01/2008
Journal of Invasive Cardiology
The Guidewire Technique for Transseptal Puncture
08/01/2008
Seiichi Haruta, MD; Hiroki Kouno, MD; Hiroshi Akanuma, MD; Hiroyuki Ichinose, MD; Tadayuki Shimakura, MD
Transseptal puncture has recently been a very important therapeutic technique in the treatment of mitral stenosis1,2 and radiofrequency ablation of a left-sided accessory pathway.3 It has increased in importance since ablation for atrial...
Transseptal puncture has recently been a very important therapeutic technique in the treatment of mitral stenosis1,2 and radiofrequency ablation of a left-sided accessory pathway.3 It has increased in importance since ablation for atrial...
Transseptal puncture has...
08/01/2008
Journal of Invasive Cardiology
Commentary
Another Trick to Improve the Safety of Transseptal Puncture
08/01/2008
Ioannis Iakovou, MD; Antonio Colombo, MD
Transseptal puncture of the interatrial septum was introduced in 1960 by Brockenbrough.1 The technique relied on fluoroscopic landmarks to identify anatomical boundaries. The movement of the tip of the needle, which resembles a “jump” from...
Transseptal puncture of the interatrial septum was introduced in 1960 by Brockenbrough.1 The technique relied on fluoroscopic landmarks to identify anatomical boundaries. The movement of the tip of the needle, which resembles a “jump” from...
Transseptal puncture of the...
08/01/2008
Journal of Invasive Cardiology
Assessment of Coronary Blood Flow in Hypertrophic Cardiomyopathy Using Thrombolysis in Myocardial Infarction Frame Count Method
08/01/2008
Ayse Saatci Yasar, MD; Hasan Turhan, MD; Ali Riza Erbay, MD; Orhan Karabal, MD; Asuman Bicer, MD; Hatice Sasmaz, MD; Ertan Yetkin, MD
Hypertrophic cardiomyopathy (HCM) is a genetically transmitted disease of the sarcomeres, characterized phenotypically by an inappropriate thickness of the interventricular septum and less frequently, of the free left ventricular wall of a...
Hypertrophic cardiomyopathy (HCM) is a genetically transmitted disease of the sarcomeres, characterized phenotypically by an inappropriate thickness of the interventricular septum and less frequently, of the free left ventricular wall of a...
Hypertrophic cardiomyopathy...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
The Transulnar Approach for Coronary Intervention: A Safe Alternative to Transradial Approach in Selected Patients
08/01/2008
Olivier F. Bertrand, MD, PhD; Robert De La Rochelliere, MD; Lionel Mangin, MD; Guy Proulx, MD; René Lemay, RN; Josep Rodés-Cabau, MD, PhD; Gérald Barbeau, MD; Can Manh Nguyen, MD; Onil Gleeton, MD; Louis Roy, MD
The transradial artery approach (TRA) for coronary interventions is now well accepted as a safe and cost-effective alternative to the traditional transfemoral approach (TFA).1,2 In our center, more than 90% of coronary interventions are...
The transradial artery approach (TRA) for coronary interventions is now well accepted as a safe and cost-effective alternative to the traditional transfemoral approach (TFA).1,2 In our center, more than 90% of coronary interventions are...
The transradial artery approach...
08/01/2008
Journal of Invasive Cardiology
Effectiveness of Acetylcysteine in Prevention of Contrast Nephropathy
08/01/2008
Lauro Bulcao, MD; Cristiane Cauduro Lima, RN; Carlos A.M. Gottschall, MD, PhD, FSCAI, FIAGS; Alexandre D. Azmus, MD; Andre Manica, MD; J. Manica, MD; Kaue Duro, MD; Marcos Frey, MD
Contrast nephropathy (CN) is a recognized complication following cardiac catheterization. Ongoing advances in catheter-based technologies have resulted in an increased number of procedures performed which, in turn, could be related to an...
Contrast nephropathy (CN) is a recognized complication following cardiac catheterization. Ongoing advances in catheter-based technologies have resulted in an increased number of procedures performed which, in turn, could be related to an...
Contrast nephropathy (CN) is a...
08/01/2008
Journal of Invasive Cardiology
Direct Thrombin Inhibitors (Part 2 of 2)
08/01/2008
Umesh K. Arora, MD; Meeney Dhir, MD
Clinical Trials of Direct Thrombin Inhibitors The 2 direct thrombin inhibitors that have been studied most extensively are hirudin and bivalirudin. The earlier trials focussed on hirudin in the setting of acute coronary syndromes, MI and PCI...
Clinical Trials of Direct Thrombin Inhibitors The 2 direct thrombin inhibitors that have been studied most extensively are hirudin and bivalirudin. The earlier trials focussed on hirudin in the setting of acute coronary syndromes, MI and PCI...
Clinical Trials of Direct...
08/01/2008
Journal of Invasive Cardiology
Electrophysiology Corner
Acute Right Coronary Artery Occlusion Following Radiofrequency Catheter Ablation of Atrial Flutter
08/01/2008
Nicolas Raio, MD; Ramesh Daggubati, MD, FACC, FSCAI; Kevin P. Marzo, MD; Todd J. Cohen, MD, FACC, FHRS
Acute coronary occlusion following radiofrequency catheter ablation has previously been reported as a very rare complication in the treatment of accessory pathways.1 We report a case of acute coronary occlusion following a routine atrial...
Acute coronary occlusion following radiofrequency catheter ablation has previously been reported as a very rare complication in the treatment of accessory pathways.1 We report a case of acute coronary occlusion following a routine atrial...
Acute coronary occlusion...
08/01/2008
Journal of Invasive Cardiology

News

thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
AI Cardiac Imaging Software
Study Reveals Stark Disconnect Between Americans’ Desire for Preventive Cardiac Screening and Care They Can Access
01/27/2026
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to...
01/27/2026
Cath Lab Digest
Patent Foramen Ovale Detection
BURL Concepts Announces First Human Uses of FOQUS Ultrasound System for Patent Foramen Ovale (PFO) Detection
01/27/2026
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system,...
01/27/2026
Cath Lab Digest
AI Plaque analysis
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
01/21/2026
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER,...
01/21/2026
Cath Lab Digest
AI Plaque analysis
Coverage Unlocks Reimbursable AI Plaque Quantification With Circle Cardiovascular Imaging's cvi42|Plaque
01/21/2026
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle...
01/21/2026
Cath Lab Digest
Acquisitions
Haemonetics Acquires Vivasure Medical Limited
01/21/2026
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite...
01/21/2026
Cath Lab Digest
Early CAD Detection
Mammograms and Hidden Heart Disease: Annual Scans Can Detect This Silent Killer and Help Save Lives, but Awareness Is Key
01/21/2026
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast...
01/21/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Demonstrates Ability to Offer Interventional Physicians Unmatched Level of Radiation Protection Thanks to First-of-Its-Kind NOVARAD Clinical Study
01/21/2026
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD...
01/21/2026
Cath Lab Digest
Technology & Health Literacy
ECRI: Misuse of AI Chatbots Tops Annual List of Health Tech Hazards
01/21/2026
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots...
01/21/2026
Cath Lab Digest
CAD Risk Factors
North Carolina State University Study Finds Police-Related Stress Associated With Physical Markers of Cardiovascular Health Risk for Black Women
01/19/2026
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related...
01/19/2026
Cath Lab Digest

Bangalore top 10
Author Interview
Editor’s 2025 Top 10: Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease
02/02/2026
Sripal Bangalore, MD, MHA; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, catches up with Dr Sripal Bangalore about his Editor’s 2025 Top 10 article, “Outcomes With Distal Transradial Access in Patients With Advanced Chronic Kidney Disease.”
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Editor's 2025 Top 10
Editor's Message
Editor’s 2025 Top 10
02/02/2026
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt, Editor-in-Chief of JIC, presents the Top 10 Articles from 2025.
Dr Deepak L. Bhatt,...
02/02/2026
Journal of Invasive Cardiology
Original Contribution
Early Outcomes of the Myval Octacor Transcatheter Heart Valve in Transcatheter Aortic Valve Implantation: A Single-Center Study From Serbia
01/30/2026
Valentina Balint, MD; Mihajlo Farkic, MD; Jovan Petrovic, MD; Matija Furtula, MD; Milos D. Babic, MD; Dragan Topic, MD; Ida Subotic, MD; Vladimir Zobenica, MD; Alfonso Ielasi, MD; Luca Testa, MD, PhD; Milovan Bojic, MD, PhD; Aleksandra Nikolic, MD, PhD
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early safety and performance of the new Myval Octacor Transcatheter Heart Valve (Meril Life Sciences).
This study evaluated the early...
01/30/2026
Journal of Invasive Cardiology
Sovari Figure 1
Clinical Videos
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter" (Clinical Image).
Video Supplement to "Right...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Right Internal Jugular Pulsed Field Ablation for Atrial Fibrillation in a Patient With an Inferior Vena Cava Filter
01/29/2026
Jeong Hwan J. Kim, MD; Leili Pourafkari, MD; Jonathan Lalezari, MD; Ali Sovari, MD
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with peripheral arterial disease, sick sinus syndrome, hypertension, and paroxysmal atrial fibrillation (AF) presented for rhythm control. He had a normally functioning dual-chamber pacemaker but had frequent symptomatic AF...
A 77-year-old man with...
01/29/2026
Journal of Invasive Cardiology
Clinical Images
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a mixed-phenotype cardiomyopathy was referred for coronary angiography because of new-onset episodes of ventricular arrythmias. At his initial presentation in 2014, he was diagnosed with hypertrophic cardiomyopathy,...
A 51-year-old man with a...
01/28/2026
Journal of Invasive Cardiology
Bradt Figure
Clinical Videos
Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker
01/28/2026
Nicolas Bradt, MD; Maxim Verlee, MD, PhD(c); Christophe Borin, MD; Hans Vandekerckhove, MD; Laurens De Vos, MD
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal Coronary Artery Fistula After Implantation of a Left Bundle Branch Area Pacemaker" (Clinical Image).
Video Supplement to "Septal...
01/28/2026
Journal of Invasive Cardiology
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
Heart Failure Devices
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
01/27/2026
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected to be one of the largest therapeutic cardiac device trials ever performed in heart failure, randomizing 2,500 patients in approximately 150 centers in the United States and Germany. The primary endpoint will...
The BENEFIT-HF trial is expected...
01/27/2026
Cath Lab Digest
HighLife TMVR
Mitral Valve Intervention
HighLife Receives CE Mark Approval for its Transcatheter Mitral Valve Replacement (TMVR) Solution
01/27/2026
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a leading MedTech company focused on transcatheter solutions for structural heart disease, today announced that it has received CE Mark approval for the HighLife Transcatheter Mitral Valve Replacement...
Paris – HighLife SAS, a...
01/27/2026
Cath Lab Digest

February 2005 Volume 17 Issue 2

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use